SciPi 145: Peer review of the genotoxicity, toxicokinetics, and carcinogenicity of a pesticide
Currently, what percentage of your funding comes from either grant or contract work from the following sources?
Results
0% | 1-10% | 10-50% | 50-75% | >75% | Total | |
---|---|---|---|---|---|---|
Government | 46.15% 6 | 23.08% 3 | 7.69% 1 | 0.00% 0 | 23.08% 3 | 13 |
Industry | 35.71% 5 | 7.14% 1 | 14.29% 2 | 14.29% 2 | 28.57% 4 | 14 |
Non-profit organizations | 58.33% 7 | 33.33% 4 | 8.33% 1 | 0.00% 0 | 0.00% 0 | 12 |
Other | 66.67% 6 | 11.11% 1 | 11.11% 1 | 0.00% 0 | 11.11% 1 | 9 |
Answer Explanations
- Expert 9
0% 1-10% 10-50% 50-75% >75% Government 1 0 0 0 0 Industry 0 0 0 0 1 Non-profit organizations 1 0 0 0 0 Other 1 0 0 0 0 i work for a pharmaceutical company.
- Expert 2
0% 1-10% 10-50% 50-75% >75% Government 0 0 1 0 0 Industry 1 0 0 0 0 Non-profit organizations 0 1 0 0 0 Other 0 0 1 0 0 Currently, I have a National Science Foundation (social science) grant for about 35% of my time, spend about 20% doing non-research work for my university (teaching, service, etc.), and the remainder involves independent consulting, expert-witness work, and pro bono work.
- Expert 4
0% 1-10% 10-50% 50-75% >75% Government 1 0 0 0 0 Industry 0 0 0 0 1 Non-profit organizations Other After spending most of my career in government I have chosen to focus most of my work (probably 90% or more) on working for non-profit organizations and university centers on a pro bono basis, although I am reimbursed for travel. For the remaining 10% or so of my efforts I work for industry clients and am paid for that work. So depending on how you define “funding” affects my answer. Since the term is used here in the context of potential conflict of interest or bias I have chosen “funding” to mean payment. However, if one defined “funding” to also include support for travel the percentages would be 10 - 50% industry, 10-50% non-profit organizations and 10-50% other (i.e. academia on a pro bono basis).
- Expert 11
0% 1-10% 10-50% 50-75% >75% Government 1 0 0 0 0 Industry 1 0 0 0 0 Non-profit organizations 1 0 0 0 0 Other 1 0 0 0 0 I have closed down my lab last year and have no more research funding due to retirement
- Expert 10
0% 1-10% 10-50% 50-75% >75% Government 0 0 0 0 1 Industry 1 0 0 0 0 Non-profit organizations 0 1 0 0 0 Other 1 0 0 0 0 My research funds come from governemental agencies (NSERC, CIHR, IRSST, ANSES and Health Canada) and the Weston Brain foundation. I have no industry funding.
- Expert 7
0% 1-10% 10-50% 50-75% >75% Government Industry 0 0 1 0 0 Non-profit organizations Other Currently, my main work with industry involves participation as a public member on the American Chemistry Council's LRI Strategic Science Team (SST), which is responsible for advising on research concerning development of 21st century testing/exposure methods. A small amount of time is spent consulting on chemicals .
- Expert 3
0% 1-10% 10-50% 50-75% >75% Government 1 0 0 0 0 Industry 1 0 0 0 0 Non-profit organizations 1 0 0 0 0 Other 0 0 0 0 1 Small projects with contracts to other consulting companies.
- Expert 6
0% 1-10% 10-50% 50-75% >75% Government 0 0 0 0 1 Industry 0 1 0 0 0 Non-profit organizations 1 0 0 0 0 Other I work for a state University in Sao Paulo, Brazil, and all my fundings come from government.
- Expert 8
0% 1-10% 10-50% 50-75% >75% Government 1 0 0 0 0 Industry 0 0 1 0 0 Non-profit organizations 0 0 1 0 0 Other 1 0 0 0 0 I am an independent consultant, and at this time have funding only from American Chemistry Council and from a non-profit organization.
- Expert 5
0% 1-10% 10-50% 50-75% >75% Government 0 1 0 0 0 Industry 0 0 0 1 0 Non-profit organizations 0 1 0 0 0 Other NIH, NYU internal funds, Bioreliance
- Expert 12
0% 1-10% 10-50% 50-75% >75% Government 0 1 0 0 0 Industry 0 0 0 1 0 Non-profit organizations 0 1 0 0 0 Other I'm a consultant working for the pharmaceutical and food industries in toxicology and pharmacology. I'm also an assistant professor at the University in the same domains.
- Expert 1
0% 1-10% 10-50% 50-75% >75% Government 0 1 0 0 0 Industry 0 0 0 0 1 Non-profit organizations 1 0 0 0 0 Other 0 1 0 0 0 Occasional re-imbursement of expenses (mostly travel) by Government or Scientific Societies. SciPinion